Market Overview

UPDATE: JP Morgan Downgrades Accuray to Underweight on Negative Pre-Announcement

Related ARAY
A Portfolio To Support Cancer Treatments In Time For Prostate Cancer Awareness Month
Morning Market Gainers

JP Morgan reduced its rating on Accuray (NASDAQ: ARAY) from Neutral to Underweight and removed its previous $8 price target.

JP Morgan noted, "Accuray (ARAY) pre-announced F2Q13 results that fell dramatically short of J.P. Morgan and Street expectations, while the company significantly cut fiscal 2013 guidance and announced a restructuring plan. … in light of competitive pressures, multiple company-specific execution issues (manufacturing challenges with new products, disruption from sales force restructuring), and the prospect of share losses and cash burn for the foreseeable future, we are downgrading our rating to Underweight and withdrawing our price target."

Accuray closed at $6.78 on Thursday.

Latest Ratings for ARAY

Nov 2015CitigroupInitiates Coverage onSell
Jan 2015Northland SecuritiesInitiates Coverage onOutperform
Jun 2014JP MorganUpgradesNeutralOverweight

View More Analyst Ratings for ARAY
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings


Related Articles (ARAY)

View Comments and Join the Discussion!

Get Benzinga's Newsletters